Who Owns PDS Biotechnology Stock?
NASDAQ: PDSBHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 1.02 +0.39%
Ownership breakdown
- Held by institutions
- 10.70%
- Held by insiders
- 19.11%
- Institutional holders
- 59
- Institutions 10.7%
- Insiders 19.1%
- Public and other 70.2%
Who owns PDS Biotechnology stock?
Institutional investors own about 10.7% of PDS Biotechnology's shares, spread across 59 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 19.11% of PDSB.
The largest institutional holders are Vanguard Capital Management LLC (3.04%), Focus Partners Wealth (1.15%) and Quantinno Capital Management, LP (1.15%). Together, the top 10 institutions control 10.4% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their PDSB positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of PDSB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 1.70M | 3.04% | +4.2% |
| Focus Partners Wealth | 642.18K | 1.15% | +100.0% |
| Quantinno Capital Management, LP | 642.18K | 1.15% | +100.0% |
| Blackrock Inc. | 607.64K | 1.09% | +9.7% |
| Geode Capital Management, LLC | 587.14K | 1.05% | -11.1% |
| Vanguard Fiduciary Trust Co | 357.14K | 0.64% | +16.2% |
| Militia Capital Management LLC | 331.80K | 0.59% | +100.0% |
| Citadel Advisors Llc | 323.80K | 0.58% | +100.0% |
| Morgan Stanley | 313.92K | 0.56% | +7904.1% |
| BLAIR WILLIAM & CO/IL | 300.00K | 0.54% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of PDSB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.04M | 1.86% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 583.95K | 1.04% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 290.95K | 0.52% |
| iShares Trust-iShares Micro-Cap ETF | 188.66K | 0.34% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 97.93K | 0.17% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 86.28K | 0.15% |
| VANGUARD Inst. INDEX Fd.S-Vanguard Inst. Total Stock Market Index Fd. | 47.62K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 27.77K | 0.05% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 25.70K | 0.05% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 12.79K | 0.02% |
Frequently asked questions
Who is the largest shareholder of PDS Biotechnology?
Vanguard Capital Management LLC is the largest institutional shareholder of PDSB, owning 3.04% of shares outstanding (1.70M shares) as of its latest 13F filing.
What percentage of PDS Biotechnology is owned by institutions?
Institutions own about 10.7% of PDSB shares and 13.2% of the public float.
How much of PDS Biotechnology do insiders own?
Insiders, such as officers and directors, own about 19.11% of PDSB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.